Ved invasiv kandidose virkede behandlingen hos 73% af de Cancidas- behandlede patienter, som kunne vurderes, (80 af 109) sammenlignet med 62% hos voksne behandlet med amphotericin B (71 af 115).
In invasive candidiasis, 73% of the adults treated with Cancidas who could be assessed had a favourable response (80 out of 109), compared with 62% of the adults treated with amphotericin B (71 out of 115).